Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-19
2007-06-19
Weber, Jon (Department: 1657)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S359000, C514S449000
Reexamination Certificate
active
11057587
ABSTRACT:
Host cells expressing HM74 were used to obtain furosemide-like molecules with agonist activity having the following structure formula:
REFERENCES:
patent: 3875150 (1975-04-01), Feit et al.
patent: 4001284 (1977-01-01), Sturm et al.
patent: 4161533 (1979-07-01), Sturm et al.
patent: 4339446 (1982-07-01), Sturm et al.
patent: 4406895 (1983-09-01), Sturm et al.
patent: 4478843 (1984-10-01), Sturm et al.
patent: 4908382 (1990-03-01), Bianco
patent: 5256687 (1993-10-01), Becker et al.
patent: 6593352 (2003-07-01), Weichert et al.
patent: 2003/0109673 (2003-06-01), Yonghong
patent: 2206424 (1972-08-01), None
patent: 2247828 (1974-04-01), None
K.F. Chung, Furosemide and Other Diuretics in Asthma, J. of Asthma, vol. 31, No. 2, 1994, pp. 85-92.
Wise et al., Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid, J. of Biological Chemistry, vol. 278, No. 11, Mar. 14, 2003, pp. 9869-9874.
Angelastro Michael
Eishingdrelo Haifeng
Kuntzweiler Theresa
Lang Hans-Jochen
Minnich Anne
Aventis Pharmaceuticals Inc.
Krupen Karen I.
Martin Paul
Sanofi-Aventis Deutschland GmbH
Weber Jon
LandOfFree
Furosemide modulators of HM74 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Furosemide modulators of HM74, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Furosemide modulators of HM74 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3867249